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Abstract: The therapeutic effect of transplantation of mesenchymal stem cells (MSCs) in 
myocardial infarction (MI) appears to be limited by poor cell viability in the injured tissue, 
which is a consequence of oxidative stress and pro-apoptotic factors. High density 
lipoprotein (HDL) reverses cholesterol transport and has anti-oxidative and anti-apoptotic 
properties. We, therefore, investigated whether HDL could protect MSCs from oxidative 
stress-induced apoptosis. MSCs derived from the bone marrow of rats were pre-incubated 
with or without HDL, and then were exposed to hydrogen peroxide (H2O2) in vitro, or were 
transplanted into experimentally infarcted hearts of rats in vivo. Pre-incubation of MSCs 
with HDL increased cell viability, reduced apoptotic indices and resulted in parallel 
decreases in reactive oxygen species (ROS) in comparison with control MSCs. Each of the 
beneficial effects of HDL on MSCs was attenuated by inhibiting the PI3K/Akt pathway. 
Preconditioning with HDL resulted in higher MSC survival rates, improved cardiac 
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remodeling and better myocardial function than in the MSC control group. Collectively, 
these results suggest that HDL may protect against H2O2-induced apoptosis in MSCs 
through activation of a PI3K/Akt pathway, and by suppressing the production of ROS. 
Keywords: high density lipoprotein; mesenchymal stem cells; oxidative stress; apoptosis; 
myocardial infarction 
 
1. Introduction 
An increasing number of studies have described transplantation of mesenchymal stem cells (MSCs) 
from bone marrow as a strategy for cardiac repair following myocardial infarction [1]. However, the 
therapeutic efficacy of this procedure is greatly limited by the poor survival of donor MSCs in the 
infarcted heart [2]. The injured myocardium represents an environment in which there are various 
factors that promote cell apoptosis, such as oxidative stress, hypoxia and inflammatory reactions [3]. 
Oxidative stress has been shown to be one of the key pro-apoptotic factors as it is present in both the 
ischemic stage and also during the reperfusion period [4,5]. Oxidative stress results in excessive 
accumulation of reactive oxygen species (ROS), which directly damages cell membranes, protein and 
DNA, thereby promoting cell senescence, compromising cell function and threatening cell   
survival [4,6]. Enhancing the viability of implanted MSCs and restoring cellular repair mechanisms are 
therefore critical factors in obtaining satisfactory outcomes with MSC-based therapy.  
It is widely reported that high density lipoprotein (HDL) lowers the risks associated with ischemic 
cardiovascular diseases [7]. HDL has been reported to possess a variety of novel and functional 
properties in addition to its ability to reverse cholesterol transport (RCT) [8]. We have previously 
demonstrated that HDL abrogates cardiac hypertrophy induced by angiotensin II by down-regulating 
the expression of angiotensin II type 1 (AT-1) receptors [9]. Other workers have shown that the effects 
of experimentally induced ROS in the vascular wall were completely abolished by a daily infusion of 
reconstituted HDL [10]. HDL has also been shown to protect endothelial cells from primary apoptosis, 
and to reduce intracellular ROS induced by oxidized low-density lipoproteins [11]. These data suggested 
that HDL might have anti-oxidative and anti-apoptotic effects in cardiovascular pathophysiology.  
We, therefore, investigated whether HDL could protect MSCs against oxidative stress-induced 
apoptosis. Additionally, we also examine the effect of HDL on the MSCs senescence, which was 
regarded to be induced by oxidative stress and to influence cell therapeutic potential considerably. 
Previously, the effects of HDL on endothelial progenitor cells [12], embryonic stem cells [13], 
hematopoietic stem cells [14] and induced pluripotent stem cells [13] have been reported, but to date 
there are no data describing the influence of HDL in the biological activity of MSCs. In the present 
study, we testified the impact of preconditioning with HDL on MSCs apoptosis and senescence 
induced by oxidative stress. In addition, hydrogen peroxide (H2O2), which is widely used as an   
oxidant [4,15], was applied in vitro to induce a form of cellular damage similar to oxidative stress. Int. J. Mol. Sci. 2012, 13 17106 
 
 
2. Results and Discussion 
2.1. HDL Protects MSCs against H2O2-Induced Apoptosis 
To investigate the effect of HDL on the biological activity of MSCs, we performed flow cytometry 
and MTS to detect cell differentiation and cell viability respectively. We observed that the MSCs 
(Passage 4), used in our experiments, expressed typical MSC-related cell surface antigens, which were 
positive for CD29, CD90 and negative for CD45, CD34; and that the incubation with HDL   
(100 μg/mL) for 24 h did not exhibit a notably impact on the characteristic phenotypes of MSCs 
(Figure S1). Meanwhile, we discovered that MSCs viability was not significantly affected by treatment 
with any of the tested concentrations of HDL (Figure 1A). Therefore, we chose a HDL concentration 
of 100 μg/mL for subsequent experiments based on methods described in previously published   
studies [9]. 
Figure 1. Effects of H2O2 and/or high density lipoprotein (HDL) on mesenchymal stem 
cell (MSC) viability and apoptosis. (A,  B) MSCs were exposed to increasing 
concentrations of HDL (0 to 200 μg/mL) or H2O2 (0 to 500 μM) for 24 h; and cell viability 
was measured by MTS assay; (A) HDL did not significantly affect MSC viability;   
(B) H2O2 decreased the viability of MSCs in a concentration-dependent manner; (C to E) 
Cells were incubated with H2O2 (400 μM) following preconditioning with or without HDL 
(100 μg/mL) for 24 h. Cell apoptosis was measured by TUNEL and caspase-3 assays as 
shown in photomicrograph C (scale bar = 20 μm) and in histogram D respectively. MSC 
viability (E) was measured by MTS assay. Results were confirmed in three, independent 
experiments. * p < 0.05 vs. Control, ** p < 0.01 vs. Control; # p < 0.05 vs. H2O2 group. 
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To determine the concentration of H2O2, which was employed to induce the cell apoptosis, MSCs 
was cultured with different concentration of H2O2 for 24 h and a MTS assay was performed 
afterwards. It was found that H2O2 impaired the viability of MSCs in a concentration-dependent 
manner over the tested concentration range (Figure 1B). The effect was statistically significant at 
concentrations over 200 μM. Based on these findings, 400 μM H2O2 was selected for use in the 
subsequent experiments. 
In order to investigate the effects of HDL on H2O2-stimulated MSC apoptosis, MSCs were 
pretreated with or without HDL (100 μg/mL) for 24 h and then cultured with 400 μM of H2O2 for an 
additional 24 h. TUNEL assay showed that incubation with 100 µg/mL HDL did not affect the 
apoptosis of MSCs (HDL group vs. Control group: (6.83 ± 1.35)% vs. (7.93 ± 1.76)%, p > 0.05). 
However, H2O2 significantly increased MSCs apoptosis (H2O2 group vs. Control group:   
(47.37 ± 7.53)% vs. (7.93 ± 1.76)%, p < 0.01), which was remarkably attenuated after preconditioning 
with HDL (HDL + H2O2 group vs. H 2O2 group: (28.77 ± 6.91)% vs. (47.37 ± 7.53)%, p < 0.05)  
(Figure 1C). Caspase-3 activity was significantly increased in H2O2-stimulated MSCs compared to 
controls ((267.4 ± 25.3)% vs. (100 ± 12.2)%, p < 0.01). The increased caspase-3 activity was 
ameliorated by pre-incubation with HDL (HDL + H2O2 group vs. H2O2 group: (130.9 ± 19.7)% vs. 
(267.4 ± 25.3)%, p < 0.05) (Figure 1D). Similarly, compared to H2O2 group, HDL pretreatment 
restored cell viability following exposure to H2O2 (HDL + H2O2 group vs. H2O2 group: (85.3 ± 7.2)% 
vs. (58.6 ± 6.8)%, p < 0.05) (Figure 1E). 
Meanwhile, MSCs aging or senescence, which directly impaired the regenerative capability, was 
widely reported to be induced by oxidative stress [16,17]. We, therefore, wondered whether HDL 
treatment could protect MSCs against H2O2-stimulated replicative exhaustion. Senescence-associated 
β-Galactosidase (SA-β-Gal) staining showed that there were no significant differences in the 
percentages of SA-β-Gal positive cells between the HDL group and the Control group   
((102.3 ± 13.7)% vs. (100 ± 12.4)%, p > 0.05). Similarly, there was nearly identical in those between 
the H2O2 group and the HDL+H2O2 group ((356.2 ± 25.8)% vs. (367.9 ± 22.37)%, p > 0.05), although 
there was a significant increment compared the H2O2 group with the Control one (p < 0.05)   
(Figure 2A). Furthermore, the MSCs senescence was confirmed by Western blot assay, suggesting that 
there were no remarkably differences in the expression of p16
INK4a between the HDL group and the 
Control ((1.06 ± 0.13) vs. (1.00 ± 0.10), p > 0.05), and between the H2O2 group and the HDL + H2O2 
group ((3.62 ± 0.19) vs. (3.40 ± 0.26), p > 0.05). Likewise, it was found that the expression of p16
INK4a 
in the H2O2 group statistically increased than that in the Control one (p < 0.05) (Figure 2B). Therefore, Int. J. Mol. Sci. 2012, 13 17108 
 
 
it indicated that HDL exerted no statistical effects on the senescence of MSCs both under a condition 
of oxidative stress and under that of control. 
Figure 2. Influence of HDL in the MSC senescence. MSCs were treated with or without 
HDL for 24 h followed by exposure to H2O2 insult for another 24 h or not;   
(A) Senescence-associated β-Galactosidase staining and representative photograms from 
three independent experiments are displayed (scale bar = 20 μm); (B) The expressions of 
p16
INK4a were detected by Western blot analysis and representative bands are shown. Data 
are shown as mean ± SE from three independent experiments. * p < 0.05 vs. Control group, 
ns., not significant; GAPDH, glyceraldehyde 3-phosphate dehydrogenase. 
 
2.2. PI3K/Akt Pathway Involves in the Protective Effect of HDL 
As previously reported [18], PI3K/Akt pathway played a critical role in the cell apoptosis. To 
examine our hypothesis that PI3K/Akt pathway was involved in the protective effect of HDL on 
MSCs, Western blot analysis was used to assess the changes in Akt phosphorylation in MSCs exposed 
to HDL with different concentration. The results indicated that incubation with HDL significantly  
up-regulated Akt phosphorylation. This response began 15 min after exposure, peaked at 
approximately 30 min (30-min group vs. Control group: (283.8 ± 25.1)% vs. (100 ± 24.71)%, p < 0.05) 
and was still present at 24 h (24-h group vs. Control group: (197.5 ± 19.37)% vs. (100 ± 24.71)%,  
p < 0.05) (Figure 3A), suggesting that HDL could enhance the activation of PI3K/Akt pathway in 
MSCs. To provide further evidence, a PI3K inhibitor, LY294002, was effectively employed to 
decrease Akt activation (LY294002 group vs. Control group: (12.37 ± 5.19)% vs. (100 ± 24.28)%,  
p < 0.05) (Figure 3B). Considering that high concentrations of LY294002 could cause a reduction in Int. J. Mol. Sci. 2012, 13 17109 
 
 
cell viability or a generation of ROS, a LY294002 group was added to examine its toxicity to MSCs. It 
was observed that LY294002, at a concentration of 25 μM, did not exhibit a statistical effect on the 
MSCs viability (LY294002 group vs. Control group: (97.6 ± 6.8)% vs. (100 ± 5.1)%, p > 0.05)   
(Figure 3C) and apoptosis (LY294002 group vs. Control group: (106.4 ± 13.5)% vs. (100 ± 11.3)%,  
p > 0.05) (Figure 3D), which was consistent with what was testified previously [19]. Intriguingly,  
the pre-treatment of LY294002 at this concentration was found to abolish the protective effect of  
HDL on H2O2-stimulated cells. This resulted in decreased cell viability as measured by MTS assay  
(HDL + H2O2 + LY294002 group vs. HDL + H2O2 + DMSO group: (51.7 ± 7.1)% vs. (83.6 ± 7.8)%,  
p < 0.05) (Figure 3C) and increased apoptosis estimated by changes in caspase-3 activity   
(HDL + H2O2 + LY294002 group vs. HDL + H2O2 + DMSO group: (286.3 ± 16.7)% vs.  
(149.5 ± 21.8)%, p < 0.05) (Figure 3D), consistently indicating that HDL protected MSCs against 
injury induced by H2O2 through PI3K/Akt pathway. 
Figure 3. Role of PI3K/Akt pathway in the HDL induced anti-apoptotic protection.   
(A) Western blot analysis show that HDL significantly increased Akt phosphorylation in 
MSCs. (B to D) MSCs were pre-incubated with LY294002 (25 μM) or DMSO for 1 h and 
then exposed to HDL (100 μg/mL) followed by exposure to H2O2 (400 μM) for a further  
24 h. Western blotting results show that Akt phosphorylation induced by HDL was 
decreased by pre-incubation with LY294002. The protective effect of HDL evidenced by 
cell viability and caspase-3 activity was significantly abolished by LY294002. Results 
were confirmed in three, independent experiments. * p < 0.05 vs. Control, ** p < 0.01 vs. 
Control, and p < 0.05 vs. H 2O2 group, § p < 0.05 vs. HDL + H2O2 + DMSO group,   
ns., not significant; DMSO, Dimethyl sulfoxide. 
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2.3. Phosphorylation of Akt Induced by HDL Inhibits ROS Generation 
The influence of the PI3K/Akt pathway in ROS production based on LY294002 inhibition and 
assessed using fluorescent probe-DHE demonstrated that the percentage of ROS negative cells with 
low fluorescence intensity were similarly observed among the Control, the HDL and the LY294002 
groups (all p > 0.05) (Figure 4). Cells with strong red fluorescent, indicating ROS accumulation, were 
more prevalent in the H2O2 group than in the Control one ((435 ± 48)% vs. (100 ± 15)%, p < 0.05). 
HDL pretreatment restored intracellular ROS generation induced by H2O2 (HDL + H2O2 group vs. 
H2O2 group: (156 ± 25)% vs. (435 ± 48)%, p  < 0.05), and the protective effect disappeared   
when the PI3K/Akt pathway was inhibited by LY294002 (HDL + H2O2 + DMSO group vs.  
HDL + H2O2 + LY294002 group: (172 ± 37)% vs. (482 ± 57)%, p < 0.01). 
Figure 4. Impact of activation of PI3K/Akt pathway induced by HDL on reactive oxygen 
species (ROS) generation. The intracellular ROS in MSCs was visualized by fluorescent 
microscopy. Representative photomicrographs (scale bar = 100 μm) and corresponding 
histograms are displayed. Preconditioning with HDL inhibited H2O2-stimulated ROS 
generation in MSCs. However, the protective effect disappeared with LY294002 
pretreatment. Results were confirmed in three independent experiments. * p < 0.05 vs. 
Control group, # p < 0.05 vs. H2O2 group, $ p < 0.05 vs. HDL + H2O2 + DMSO group,  
ns., not significant; DMSO, Dimethyl sulfoxide. 
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The above results showed that the inhibition of PI3K/Akt pathway attenuated the protective effect 
of HDL and the decreased ROS, indicating that Akt activation was partly upstream of ROS generation. 
Excessive production of ROS has been shown to damage stem cells through caspase-mediated 
pathways [20]. Therefore, these findings suggested that HDL activation of the PI3K/Akt pathway 
might inhibit ROS generation, and thereby reduce apoptosis of implanted MSCs. 
2.4. HDL Pre-Incubation Promotes MSC Survival in the Infarcted Heart 
The poor viability of the donor cell, typically <1% at 4 days after transplantation, has been reported 
in the previous study regarding MSCs-base therapy [5]. Therefore, we testified the effect of HDL 
preconditioning on the survival of MSCs on Day 4 after transplantation in vivo (Figure 5A,B). After a 
GFP-labeling and the pre-incubation with or without HDL (100 μg/mL), MSCs (1 × 10
6 in 100 μL) 
were respectively transplanted into the infarcted heart of rats. It was discovered that the number of 
GFP
+ MSCs per HP in the HDL-MSCs group was 2.58-fold greater than that in the MSCs group  
(p < 0.05). Furthermore, when we transplanted the male MSCs to the female hearts, it was revealed 
that the sry DNA level in the HDL-MSCs group was approximately 2.83-fold higher than that in the 
MSCs group (p < 0.05), indicating that HDL preconditioning could enhance the survival of MSCs  
after transplantation.  
2.5. MSCs Preconditioned with HDL Reduce Cardiac Remodeling and Preserve Myocardial Function 
The effect of MSCs preconditioned with HDL on cardiac function was observed by transthoracic 
echocardiography four weeks after experimentally induced MI in rats (Figure 5C,D). It indicated that 
left ventricular ejection fraction (LVEF) was 50.8% lower in the PBS group than in the Sham group 
and LVFS was 53.0% lower in the PBS group than in the Sham group (both p < 0.05); and that LVIDd 
was 40.9% higher and LVIDs was 90.0% higher in the PBS than in the Sham group (both p < 0.05). 
Furthermore, compared with PBS group, transplantation of MSCs improved LVEF and LVFS by 
13.0% and 21.6%, respectively (both p < 0.05). Injection of HDL-MSCs enhanced the LVEF and Int. J. Mol. Sci. 2012, 13 17112 
 
 
LVFS by an additional 13.0% and 20.1%, respectively (both p < 0.05). Transplantation of MSCs 
decreased the LVIDd and LVIDs by 19.5% and 23.3%, respectively compared to the PBS group (both 
p < 0.05), and transplantation of HDL-MSCs further decreased LVIDd and LVIDs by approximately 
12.3% and 30.0% (both p < 0.05), respectively. 
Figure 5. Effects of HDL preconditioning on transplanted MSCs survival and cardiac 
function in the rats with experimental MI. (A and B) The number of GFP
+ MCSs was 
counted under fluorescent microscopy four days after injection. Representative 
photomicrographs (A, scale bar = 100 μm) and the corresponding histogram are displayed. 
Male sry DNA was examined by real-time PCR. n = 7 per group. * p < 0.05 vs. MSCs 
group. (C and D) four weeks after therapeutic intervention, transthoracic echocardiography 
was performed to evaluate cardiac remodeling and LV function. Representative M-mode 
echocardiograms and quantitative data are shown. n = 8 per group. * p < 0.05 vs. PBS 
group, # p < 0.05 vs. MSCs group. 
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We noticed that Kiya Y et al. [21] had previously reported that continual infusion of HDL 
following MI prevented LV remodeling and improved myocardial function in rats. Though they 
attributed the better prognosis to an improvement of the survival of cardiomyocytes resulting from 
treatment with HDL, they had not well explored the influence of HDL on the cells that migrated to 
injured myocardium, such as MSCs. And our results from the present study might partly provided the 
evidences on a novel perspective to support their finding as follows: a higher level of HDL might 
improve the anti-apoptotic capability of MSCs, which were mobilized to the damaged myocardial 
region, thus contributing to the myocardial regeneration, bringing about a better cardiac function   
after MI. 
In the recent literature, the effect of transplantation of MSCs on myocardial repair was reported as 
confined for the low viability of graft cells [1,22]. For instance, even 6 × 10
7 implanted MSCs in 
infarcted porcine hearts yielded only limited enhancement of LVEF [23]. A series of pharmacological 
preconditioning was thought to be an effective approach for promoting MSCs survival [24] but had the 
potential to cause severe side effects in patients with cardiovascular diseases.  
Therefore, we explored whether improving the in-situ physiological environment of MSCs could 
enhance cells viability and prevent oxidative stress-induced apoptosis after transplantation or 
mobilization. Epidemiological studies have consistently shown an inverse correlation between HDL 
levels and outcomes in ischemic heart diseases [8]. We endeavored to elucidate this correlation with a 
hypothesis that HDL might promote survival of implanted MSCs, ameliorate their capacity to repair 
damaged tissue and thereby improve clinical prognosis. In support of this hypothesis, our data 
indicated that HDL protected MSCs from apoptosis induced by H2O2 in vitro. The mechanisms 
involved activation of PI3K/Akt pathway, which was consistent with findings from previously reported 
studies [15,22]. We also demonstrated that the anti-apoptotic effect of HDL enhanced survival of 
MSCs and improved myocardial repair in vivo, supporting the findings of previous researches showing 
that the administration of HDL preserved the post-ischemic cardiac function [25]. 
Beside apoptosis, cellular senescence had been proved to be the other main outcome following 
oxidative stress stimuli [16], which considerably impaired MSCs therapeutical properties. On the other 
hand, there were several literature suggesting that a higher level of HDL was associated with a slower 
rate of leukocyte telomere length shortening per year [26]; and that offspring of individuals with 
exceptional longevity had significantly larger HDL, which hinted that HDL was probably involved in 
the cellular aging [27]. Considering those evidences, we carried out the parallel experiments to 
investigate whether HDL could play a critical role in the protective effect on MSCs senescence 
stimulated by oxidative stress. H2O2 treatment expectably spurred a considerable replicative 
exhaustion in MSCs; however, MSCs senescence could not be reversed by HDL preconditioning, 
which indicated that the effectiveness of HDL on the MSCs therapeutical potential in vivo was 
independent on the influence in cellular aging, while mainly through enhancement in cellular   
anti-apoptotic property. Indeed, the elucidation of this mechanism is especially critical for physicians 
engaged in cell-based therapy, whom must be sure that MSCs are devoid of chromosome alterations 
and that there are no signs of cellular senescence. 
The clinical significance of our results is the possible benefit of HDL in patients with myocardial 
infarction in terms of improving the survival of transplanted MSCs. Elevation of HDL levels in 
patients, at high risk of cardiovascular disease may also be of vital clinical importance in preventing Int. J. Mol. Sci. 2012, 13 17114 
 
 
cardiovascular events. However, we did not identify the specific components of HDL that were 
responsible for its anti-oxidant and anti-apoptotic effects in the present study, for HDL is a lipoprotein, 
containing HDL2 and HDL3, with a density ranged from 1.063 to 1.210 g/mL [28]. This will be the 
subject of future research, along with an investigation of other potential effects of HDL on MSCs  
(such as promotion of secretion); that may contribute to the restoration of cardiac function in vivo. 
3. Experimental Section  
3.1. Isolation and Culture of MSCs 
All animal procedures were undertaken in accordance with the Guidelines for the Care and Use of 
Laboratory Animals, published by the National Academy Press (NIH Publication No. 85–23, Revised 
1996). The experiments were approved by the Animal Care and Use Committee of Zhongshan 
Hospital, Fudan University.  
MSCs were isolated from four-week-old Sprague-Dawley (SD) rats weighing 100 to 120 g by 
flushing femurs and tibias with Dulbecco’s modified Eagle’s medium (DMEM; GIBCO), 10% Fetal 
Bovine Serum (FBS; GIBCO) and penicillin/streptomycin. The bone marrow (BM) solution was 
cultured at 37 °C in an atmosphere of 5% CO2. The culture medium was changed every 3–4 days.  
Non-adherent hematopoietic cells were removed during this process, and the adherent, spindle-shaped 
MSCs were cultured and expanded. Passage 4 cells were used for subsequent experiments.  
3.2. Adenoviral Transduction and Labeling of MSCs 
An adenoviral vector carrying a green fluorescent protein (GFP) (GeneChem) for cell transduction 
was used to establish and identify a stable population of MSCs. Transduction was facilitated by 
transfecting Passage 4 MSCs with purified adenovirus cells that had been exposed to 7 μg/mL 
polybrene. The transfected cells were incubated for 24 h at 37 °C with 5% CO2. The medium was 
removed, replaced with fresh medium and incubated for a further 24 h. Cells were then sorted by flow 
cytometry for GFP to ensure that a homogenous population of GFP
+ MSCs was obtained (data were 
not shown). 
3.3. In vitro Exposure to H2O2 and HDL 
MSCs were incubated for 6 h with DMEM supplemented with 1% FBS prior to experimental 
interventions. The starved MSCs were then respectively exposed to H2O2 (0 to 500 μM) or HDL (0 to 
200 μg/mL; Merck) for 24 h. The experiments were undertaken in four groups: a control group; a HDL 
group (MSCs incubated with HDL 100 μg/mL for 24 h); a H2O2 group (incubation with 400 μM H2O2 
for 24 h); a HDL + H2O2 group (pre-incubation with HDL 100 μg/mL for 24 h, followed by 24-h 
exposure to 400 μM H2O2). For inhibitor experiments, three additional groups were set as follows: 
MSCs were pre-incubated with PI3K inhibitor (LY294002, 25 μM) or vehicle (DMSO) for 1 h, and 
then successively treated with HDL and H2O2 as above; the third group was pre-cultured with 
LY294002 alone. The concentrations of HDL, H2O2 and LY294002 used in these experiments were 
determined from pilot studies and based on similar methods described in the literature [9,19,29]. Int. J. Mol. Sci. 2012, 13 17115 
 
 
3.4. MSC Viability Assay 
MSC viability was assessed using a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2- 
(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay. Cells were cultured in 24-well plates and 
treated according to the protocol. After 24 h, Cell Titer 96
® Aqueous One Solution Reagent (Promega) 
was added to each well according to the manufacturer’s instructions. Cell viability was evaluated after 
2-h incubation with this reagent, by testing absorbance at 490 nm using a plate reader. 
3.5. TUNEL (Terminal Dexynucleotidyl Transferase-Mediated dUTP Nick end Labeling) Assay 
Cell apoptosis was investigated using an In Situ Cell Death Detection kit (Roche). In brief, MSCs 
were fixed in 3.7% buffered formaldehyde, pretreated with 3.0% H2O2 and exposed to TdT enzyme at 
37 °C for 1 h. The cells were then incubated with digoxigenin-conjugated nucleotide substrate at 37 °C 
for 30 min. Nuclei exhibiting DNA fragmentation were identified after staining with 3,3-diamino 
benzidine (DAB) for 5 min.  
The MSCs were counterstained with hematoxylin and viewed by light microscopy. Five fields at 
high magnification (×200) were randomly chosen to assess the apoptosis index, which was calculated 
as a percentage of labeled cells to total nuclei. 
3.6. Caspase-3 Activity Assay 
Caspase-3 activity was determined in MSC lysates (200 μg) using Caspase-3/CPP32 Fluorometric 
Assay kit (BioVision). The fluorogenic CPP32/caspase-3 substrate was labeled with the fluorochrome 
7-amino-4-methyl coumarin. In this assay, the amount of fluorescence produced upon cleavage was 
proportional to the amount of caspase-3 activity present in the sample.  
3.7. Senescence-Associated β-Galactosidase Staining 
MSCs cultured in six-well plates were rinsed with phosphate-buffered saline (PBS), fixed and then 
incubated with freshly prepared senescence-associated β-Galactosidase (SA-β-Gal) staining solution 
(Beyotime, China) at 37 °C overnight. Five fields at high magnification (×200) were randomly chosen 
to count the number of blue cells (SA-β-Gal positive cells). At least 500 cells in each group were 
examined and the percentages of blue cells presented. 
3.8. Western Blot Analysis 
MSCs from each group were rinsed with cold PBS and lysed using RIPA buffer containing 1 mM 
phenylmethanesulfonylfluoride on ice for 30 min. The lysates were transferred to 1.5 mL Eppendorf 
tubes and centrifuged at 4 °C and 15,000 rpm for 30 min. The protein component was separated by 
12% SDS-PAGE and then transferred to polyvinylidene fluoride membranes (Millipore). The 
membranes were blocked in 5% skimmed milk for 2 h at room temperature, and were incubated 
overnight at 4 °C with anti-phospho-Akt (Cell Signaling), anti-Akt (Cell Signaling), anti-p16
INK4a. 
Following a 30 min wash, the membranes were incubated for 1 h with a secondary antibody 
conjugated to horseradish peroxidase-conjugated IgG (Jackson). Protein expression was determined Int. J. Mol. Sci. 2012, 13 17116 
 
 
using an enhanced chemiluminescence system and quantified by densitometry (Image System;   
Bio-Rad). 
3.9. Measurement of ROS 
The production of intracellular ROS was measured using an oxidation-sensitive fluorescent 
dihydroethidium (DHE) probe (Vigorous). The assay was based on the principle that DHE crosses cell 
membranes and is rapidly oxidized in the presence of ROS resulting in the formation of a highly 
fluorescent form of oxidative ethidium. 
In this assay MSCs were washed three-times with PBS and incubated with 10 μM DHE in   
phenol-red-free MEM medium (Invitrogen) at 37 °C in the dark. After 15 min incubation, the cells 
were rinsed and the medium was replaced. The fluorescence level, as an indicator of ROS production, 
was detected using fluorescence microscopy. The excitation and emission filters were 488 nm and  
590 nm, respectively. 
3.10. Myocardial Infarction and MSCs Transplantation 
The MI model was developed in SD rats (220 ± 30 g), as previously described [22]. MSCs (1 × 10
6 
in 100 μL, derived from male rats) (MSCs group) or MSCs preconditioned with HDL (HDL-MSCs 
group) were intramyocardially injected into female rats 10 min after ligation-induced infarction. The 
MSCs were injected into 3 to 5 injection sites into the anterior aspect of the viable myocardium that 
bordered the area of infarction. For the experiments concerning cardiac remodeling, two additional 
groups were set as follows: rats received intramyocardial injection of 100 μL of PBS without MSCs 
(PBS group) or received thoracotomy only but were not ligated (Sham group).  
3.11. Tracking of the GFP
+ MSCs Injected in MI Hearts 
To observe the donor MSCs survival in vivo, rats were sacrificed four days after cell implantation. 
Hearts were harvested and sliced transversally above the ligation suture. Tissue fixation was 
minimized to reduce autofluorescence. The sample was embedded at optimum cutting temperature and 
cut by a cryostat from the base (above the ligation) towards the apex until the ligation suture was 
reached. Beginning at this point, 10 μm sections were collected throughout the entire lesion. The 
sections were stained using DAPI (4,6-diamidino-2-phenylindole), and the number of GFP
+ MSCs was 
estimated under fluorescent microscopy at a magnification of ×200.  
Three photomicrographs were taken from the infarct border zone of each section. Six sections were 
selected for counting, giving a total of 18 high power fields per rat. The numbers of GFP
+ MSCs were 
counted and averaged. 
3.12. Real-Time Polymerase Chain Reaction 
Real-time polymerase chain reaction (PCR) was performed for quantification of the male sry DNA 
levels on Day 4 after cell transplantation. Rats were sacrificed and hearts were excised, frozen in liquid 
nitrogen and powdered. DNA purification was performed using Genomic DNA Isolation kit (Qiagen). 
The concentration of the purified DNA was determined by spectrophotometry. Real-time PCR was Int. J. Mol. Sci. 2012, 13 17117 
 
 
performed using Takara SYBR Premix Ex TaqTM in a Bio-Rad iQ5 optical module. Primers for 
amplification of rat Y chromosome sry and β-actin genes were synthesized (Invitrogen) and were 
listed as follows: sry, forward, 5'-GAG GCA CAA GTT GGC TCA ACA-3'; reverse, 5'-CTC CTG 
CAA AAA GGG CCT TT-3'. β-actin, forward, 5'-CCA TTG AAC ACG GCA TTG-3'; reverse,   
5'-TAC GAC CAG AGG CAT ACA-3'. The cycling conditions were: 30 s at 95 °C, followed by  
40 cycles of 5 s at 95 °C, 30 s at 59.5 °C, 30 s at 72 °C. Melting curves were acquired at the end of  
the reaction by gradually raising the temperature by 1 °C/min from 59.5 °C to 95 °C over a time period 
of 35 min. 
3.13. Echocardiography 
Cardiac remodeling and left ventricular function were assessed by transthoracic echocardiography  
4 weeks after MI, using a Vevo 770 high-resolution imaging system (Visual Sonics) with a 17.5-MHz 
probe. After the induction of light general anesthesia, hearts were imaged in two dimensional and  
M-modes. The recordings were obtained in the para-sternal long-axis view at the level of the greatest 
LV diameter. The LV internal end-diastolic diameter (LVIDd) and LV internal end-systolic diameter 
(LVIDs) were measured from M-mode recordings according to the leading-edge method. All 
echocardiographic measurements were averaged from at least five separate cardiac cycles. 
3.14. Statistical Analysis 
Statistical analysis was undertaken using SPSS version 16.0. All data were expressed as means and 
standard errors (SE). Between-group of differences was analyzed using Student’s t-test. Comparisons 
between more than two groups were performed using one-way analysis of variance (ANOVA) with 
Bonferroni’s correction. Values of p < 0.05 were considered statistically significant. 
4. Conclusions  
In summary, we demonstrated that HDL protected MSCs from H2O2-induced apoptosis by 
activation of the PI3K/Akt pathway and down-regulation of ROS generation; and that preconditioning 
with HDL promoted MSCs survival after cell transplantation, thereby preserving cardiac function. This 
observation provides an experimental basis for improving the prognosis of patients with myocardial 
infarction through elevation of HDL levels. The HDL-based therapy may hold the promise of reducing 
the incidences of such left ventricular remodeling and heart failure after myocardial damage. 
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